These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14221679)

  • 1. CAPREOMYCIN SUSCEPTIBILITY OF STRAINS RESISTANT TO STREPTOMYCIN AND/OR VIOMYCIN.
    VERBIST L; GYSELEN A
    Am Rev Respir Dis; 1964 Oct; 90():640-1. PubMed ID: 14221679
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTIVITIES IN BLOOD OF SEVERAL ANTIMYCOBACTERIAL DRUGS DETERMINED BY THE SLIDE CELL CULTURE METHOD AS COMPARED WITH IN VITRO ACTIVITIES. I. CONCERNING STREPTOMYCIN, KANAMYCIN, CAPREOMYCIN AND VIOMYCIN].
    NAGATA A; MATSUMOTO M; MASE M
    Kekkaku; 1965 Jan; 40():6-11. PubMed ID: 14288531
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK; Kanes W; Davidson PT; Moulding TS
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AMBULATORY AND HOSPITAL THERAPY OF TUBERCULOSIS].
    TANNER E
    Schweiz Med Wochenschr; 1964 Jun; 94():848-52. PubMed ID: 14250319
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
    Kozulitsyna TI; Kozlova NV
    Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on cross resistance in Mycobacterium tuberculosis, with special reference to streptomycin-, kanamycin-, and viomycin resistance.
    TSUKAMURA M; YAMAMOTO M; HAYASHI M; NODA Y; TORII F
    Am Rev Respir Dis; 1962 Mar; 85():427-31. PubMed ID: 13922900
    [No Abstract]   [Full Text] [Related]  

  • 12. SOME SIMPLE METHODS OF IDENTIFYING NONPHOTOCHROMOGENIC ANONYMOUS MYCOBACTERIA (BATTEY TYPE).
    VIRTANEN S
    Ann Med Exp Biol Fenn; 1963; 41():554-9. PubMed ID: 14078784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDIES ON DIFFERENCES IN EXPRESSION OF THE IN VITRO ACTIVITY OF ANTITUBERCULAR AGENTS IN VARIOUS COLONY-COUNTABLE MEDIA. 1. DIFFERENCES IN THE ANTIBACTERIAL STRENGTH ON OGAWA'S 1-PERCENT MEDIUM, KIRCHNER'S AGAR SLANT, AND KIRCHNER'S SEMISOLID AGAR].
    KAKU R
    Kekkaku; 1963 Nov; 38():517-23. PubMed ID: 14134127
    [No Abstract]   [Full Text] [Related]  

  • 18. [SOME CONSIDERATIONS ON THE RESISTANCE OF KOCH BACILLI TO ANTIBIOTICS AND ON ITS PRACTICAL IMPORTANCE].
    SANTOS JC
    J Med (Oporto); 1964 Jun; 54():326-30. PubMed ID: 14160477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research on the bacteriostatic effect of viomycin and of the association of viomycin and streptomycin on Koch's bacilli].
    MASI A; MOGGI P
    Riv Clin Pediatr; 1951 Jul; 49(7):517-25. PubMed ID: 14883750
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.